Common Household Spice Could Mess With Your Medications
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
A new study suggested that certain types of cinnamon products could interfere with some medications due to their metabolic impacts.
Researchers from the National Center for Natural Products Research (NCNPR) at the University of Mississippi illustrated this by testing the absorption of medications following cinnamon intake in a material simulating fasting gastric fluid.
"People who suffer from chronic diseases – like hypertension, diabetes, cancer, arthritis, asthma, obesity, HIV, AIDS or depression – should be cautious when using cinnamon or any other supplements," Shabana Khan, a principal scientist in the natural products center, said in the press release, adding "By definition, supplements are not meant to treat, cure or mitigate any disease."
Why It Matters
The common spice is found in many homes, restaurants, and coffee houses and while researchers say having a little of it is harmless, larger quantities could cause potential medication efficacy issues.
It has long been known to have good metabolic and anti-inflammatory properties and thus has been marketed as supplements in different forms, including oils, powder and capsules.
What To Know
The study from the NCNPR says not knowing the source and quantity of cinnamaldehyde in the cinnamon can create dangerous situations, especially for those with chronic conditions like diabetes, heart disease, cancer and depression.
When taken in large doses, like those which can be found in some supplements, it can lead to a change in how quickly the large intestine can absorb the medicine, and thus, how effective the treatment will be on an individual.
Researchers tested using cinnamaldehyde, the active component that gives the spice its scent and flavor.
They found that the absorption of medications into the simulated gastric fluid was slowed after adding cinnamaldehyde in comparison to the fluid that did not have it added.
While the results aren't definitive, they do point in a direction of danger, leading researchers to caution medication takers and seek further research.
NCNPR Associate Director Amar Chittiboyina said the issues don't extend to all cinnamon products.
He said cinnamon oil doesn't have the same risk of drug interactions as cinnamon bark, which can have a large amount of coumarin, a blood thinner. This is mostly found in Cassia cinnamon from southern China, according to Chittiboyina.
"In contrast, true cinnamon from Sri Lanka carries a lower risk due to its reduced coumarin content," he explained in the press release. "Coumarin's anticoagulant properties can be hazardous for individuals on blood thinners."
In this stock image, cinnamon is seen in Berlin on January 20.
In this stock image, cinnamon is seen in Berlin on January 20.What People Are Saying
Bill Gurley, a principal scientist in the Ole Miss center and co-author of the study, said: "We know there's a potential for cinnamaldehyde to activate these receptors that can pose a risk for drug interactions. That's what could happen, but we won't know exactly what will happen until we do a clinical study."
Shabana Khan, a principal scientist in the natural products center, said in the press release: "Health concerns could arise if excessive amounts of supplements are consumed without the knowledge of health care provider or prescriber of the medications. Overconsumption of supplements could lead to a rapid clearance of the prescription medicine from the body, and that could result in making the medicine less effective."
What Happens Next?
Gurley said a clinical study is needed to further study the effects of cinnamaldehyde on patients' medication consumption and efficacy of those medications.
While those studies are not yet completed, researchers say people should talk to their doctor before adding any cinnamon supplements to their diet in addition to medications.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
9 minutes ago
- UPI
Supportive doctors help LGBTQ patients stay healthier
Marchers carry a pride banner in the WorldPride 2025 Parade in Washington on Saturday. A study shows supportive care boosts the health of the LGBTQ community and cuts costs. File Photo by Leigh Vogel/UPI | License Photo June 10 (UPI) -- When LGBTQ+ patients are unsure if they can be open about their identity and related health needs, it becomes more difficult for them to access high-quality health care. In our recently published research, my colleagues and I found that how LGBTQ+ people are treated at the doctor's office has a measurable effect on whether they stay up to date with lifesaving preventive care like flu shots, colorectal cancer screenings and HIV testing. Results of affirming care We examined how LGBTQ+ adults rated their health care provider across three areas: LGBTQ+ cultural competency, such as if providers used inclusive language on forms and in person; LGBTQ+ clinical competency, such as their doctor's knowledge on all aspects of their health; and experiences of discrimination, such as being told to seek care elsewhere. After analyzing survey data on the experiences of more than 950 LGBTQ+ adults from across the U.S., we saw that three clear patterns emerged. First, 34% of participants reported having positive health care experiences - meaning their providers were culturally and clinically competent about LGBTQ+ health needs, and did not discriminate against them. These patients were more likely to be up to date on at least one preventive service recommended by the U.S. Preventive Services Task Force, compared to those receiving neutral or discriminatory care. Second, 60% of participants reported having neutral experiences, when their providers were clinically competent about LGBTQ+ health needs and didn't discriminate against them, but were not culturally competent. These patients were 43% less likely to get an HIV test compared to patients reporting affirming care. Third, 6% of participants reported experiencing discrimination, when their providers were neither culturally nor clinically competent on LGBTQ+ health. These patients were 24% less likely to get a colorectal cancer screening compared to patients reporting affirming care. Most LGBTQ+ adults in our study reported neutral or even discriminatory care, which leads to avoidable health risks and higher costs for the health system. This provides additional evidence that being supportive of LGBTQ+ patients has measurable improvements for health outcomes. Why preventive care matters Preventive care saves lives and saves money. When diseases like colorectal cancer or HIV are caught early, treatments are often simpler, more effective and less expensive. When LGBTQ+ patients are made to feel unwelcome or unsafe, we found that they are less likely to get routine preventive care, ultimately driving up long-term costs across the health system. States like North Carolina and Georgia that have more health systems participating in the Human Rights Campaign's Healthcare Equality Index, which evaluates policies and practices around LGBTQ+ care, had higher rates of LGBTQ+ patients reporting positive care experiences compared to states with few participating health systems, such as Tennessee and Alabama. Other researchers have found that health systems participating in the Healthcare Equality Index have lower rates of nurse burnout and better quality of care, along with higher patient satisfaction among all patients. Public health in crisis This study was originally funded by the National Institute on Aging, but it was among the first LGBTQ+-focused projects terminated by the Trump administration in its efforts to eliminate "gender ideology." Our team has continued the work independently to ensure that the over 1,250 participants who already shared their experiences and data would not have this information sit idly. Our findings reinforce what many LGBTQ+ patients already know - nonjudgmental and competent care is not a luxury, but a public health necessity. University of Illinois Chicago. This article is republished from The Conversation under a Creative Commons license. Read the original article. The views and opinions expressed in this commentary are solely those of the author.
Newsweek
23 minutes ago
- Newsweek
Target Recall Update as Consumers Told to Immediately Stop Using Products
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Target has warned customers to stop using various products they purchased from the retailer due to safety concerns. The products were manufactured by various companies but sold in Target stores nationwide or on its website. Some of the products include a potentially dangerous pressure cooker lid that could cause burns and a cooler that poses a "fingertip amputation" risk. Newsweek reached out to Target via email for comment. Why It Matters Recalls are issued if there are concerns that a product may be harmful in some way, such as when testing reveals that products are infected with potentially deadly bacteria, or amid fears that foods could be contaminated with a foreign object from the manufacturing process. Consumers have various rights when an item they've purchased is hit by a recall, with food recalls typically offering full refunds. A Target store in Jersey City, New Jersey, as seen on May 17, 2025. A Target store in Jersey City, New Jersey, as seen on May 17, 2025. Getty Images What To Know Target alerts its customers to any current or ongoing product recalls on its website. Various items were pulled from shelves back in March, ranging from fears that teething sticks could be a choking hazard to concerns about the particular batteries in a microphone potentially overheating and igniting. The most recent news from the retail chain reveals that three product recalls have been issued since May, with two recalls occurring last month and one in the first week of June: BowFlex 552 Adjustable Dumbbells and BowFlex 1090 Adjustable Dumbbells, recalled on June 5 The exercise weights were sold in stores and online. Shoppers were told that they should "immediately stop using [them]," with the retailer warning: "The weight plates can dislodge from the handle during use, posing an impact hazard." Customers should contact Johnson Health Tech Trading or BowFlex Inc. to request a refund and return the items, Target said. Igloo 90 Qt. Flip & Tow Rolling Coolers, recalled on May 8 This cooler, which is set on wheels with a pull-handle, has been recalled because the "tow handle can pinch consumers' fingertips against the cooler, posing fingertip amputation and crushing hazards." Customers who bought the coolers were urged to "contact Igloo for a free replacement handle." SharkNinja Foodi OP300 Series Multi-Function Pressure Cookers, recalled on May 1 Target customers were warned to "immediately stop using the product's pressure-cooking function and contact SharkNinja for a free replacement lid. Consumers can continue to use the product's air frying and other functions." The retailers said the reason for the lid replacement is due to a fault with the existing pressure cooker lid, which "can be opened during use, causing hot contents to escape, posing a risk of burn injuries to consumers." What People Are Saying Target, in a statement on its website: "At Target, our purpose is to help all families discover the joy of everyday life. It is who we are, how we work, and what we value. Our guests, your safety, is our highest priority. For this reason, we maintain a comprehensive list of our recalled products." What Happens Next Customers should follow the relevant advice provided by Target for each product recall and continue to check Target's website for the most up-to-date recall notices.
Bloomberg
an hour ago
- Bloomberg
FDA Pauses Trials of Gilead HIV Combination After Safety Signal
Gilead Sciences Inc. said federal regulators had placed on hold trials of a new experimental once-weekly HIV drug combination therapy after white blood cell counts dropped in some of the patients. The studies were testing two experimental HIV drugs, GS-1720 and GS-4182, when given together. Gilead said the Food and Drug Administration paused the trials due to a ' safety signal ' triggered by a decrease in lymphocyte levels in some patients given the therapy. Lymphocytes are a type of white blood cell that play a critical role in the immune system's ability to fight infections.
